Lab Work for GU/ Kidney Disorder: 19.4% of denials overturned
In 36 California IMR decisions from 2014 to 2026, reviewers overturned 7 (19.4%). In the last five years: 20.7% of 29. 2 were medical-necessity disputes, 34 experimental/investigational.
By year (last five)
| Year | Decisions | Overturned |
|---|---|---|
| 2021 | 1 | 0.0% |
| 2022 | 2 | 50.0% |
| 2023 | 1 | 0.0% |
| 2024 | 8 | 25.0% |
| 2025 | 16 | 18.8% |
| 2026 | 1 | 0.0% |
What the findings mention
| What the findings mention | Decisions | Overturned | All decisions here |
|---|---|---|---|
| Guidelines or criteria citedThe findings cite guidelines, criteria or a standard of care. | 8 | 25.0% | 19.4% |
| Published evidence citedThe findings refer to peer-reviewed or published evidence. | 8 | 37.5% | 19.4% |
| Records did not supportThe findings say the documentation did not show what was needed (usually an upheld denial). | 5 | 0.0% | 19.4% |
Keyword matches on the reviewer’s findings, not causes. A tag that appears mostly in overturned decisions is worth documenting in an appeal; it is not a guarantee.
From recent overturned decisions
“The physician reviewer found that a patient has requested reimbursement for a bacterial vaginosis lab test.The enrollee had ongoing symptoms despite prior treatment. Determining the etiology of vaginitis is important before initiating therapy. The enrollee underwent molecular testing to evaluate potential infectious causes. This is a U.S. Food and Drug Administration (FDA)-cleared molecular test that detects bacterial vaginosis, Candida species, …”
“The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient has requested reimbursement for a Bacterial Vaginosis (BV) lab test. The standard diagnosis of BV involves office-based testing of samples of vaginal discharge using the Amsel criteria, with the presence of three of the following four criteria making the diagnosis of BV: a) homogeneous, thin, discharge that smoothly …”
“The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient has requested reimbursement for multitarget polymerase chain reaction (PCR) testing for the diagnosis of bacterial vaginosis. Vaginal culture has traditionally been the gold standard for diagnosing vulvovaginal candidiasis. However, in clinical practice, culture has been replaced by nucleic acid amplification tests (NAATs) because they can provide results more …”
And one the reviewer upheld
“The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient has requested reimbursement for a multianalyte assay with algorithmic analysis. In this case, the records do not establish a documented history of recurrent or refractory vaginitis. The patient’s primary symptoms were consistent with a urinary tract infection, which was treated appropriately. Additionally, according to the American College of …”
- California only: these are decisions by independent reviewers under California's IMR program (plans regulated by the Department of Managed Health Care). Other states and self-funded employer plans use different reviewers and rules.
- Selection: only denials that a member took all the way to IMR appear. Most denials are never appealed, and the ones that reach an external reviewer are not a random sample.
- Overturned means the reviewer disagreed with the plan; it does not mean the treatment worked or that a similar request will be approved.
- Argument tags are keyword matches on the reviewer's findings. They describe what the findings mention, not why the case was decided.
- Categories are DMHC's own labels (treatment sub-category and diagnosis category); 'Other' is a catch-all and is excluded from rankings.
Source: California Department of Managed Health Care, Independent Medical Review (IMR) Determinations, Trend (CHHS Open Data). Public California government data; Apellica's aggregates and tags are CC BY 4.0.
Questions
How often were Lab Work denials for GU/ Kidney Disorder overturned?
In 36 California IMR decisions from 2014 to 2026, reviewers overturned 7 (19.4%). In the last five years: 20.7% of 29. 2 were medical-necessity disputes, 34 experimental/investigational.
What should an appeal document, based on these findings?
Whatever the plan's criteria ask for, shown in the record: the treatments already tried and their results, contraindications to the plan's preferred option, the guideline or evidence that supports the request, and the treating clinician's reasoning written to the criteria. The tag table shows which of these the reviewers mentioned most in overturned cases.
Does a California IMR result apply to my plan?
Only California plans regulated by the Department of Managed Health Care go to IMR. Other states and self-funded employer plans use different reviewers, but they weigh the same things.
Independent reviewers reverse plans when the record answers the criteria. Upload the denial letter; a senior reviewer reads it within 24 hours and tells you in writing whether it can be appealed and how. $0 upfront, 10% of what is recovered, nothing if we do not recover. Not a law firm.